Canada must invest in full spectrum of isotope production

In the fight against cancer, our strength will come from collaborating within the isotope industry and across sectors to deliver the best options to patients.

Bruce Power is the first nuclear power reactor in the world to produce lutetium-177, used to treat a growing number of cancers, in its specialized Isotope Production System, writes James Scongack. Photograph courtesy of Bruce Power/Wikimedia Commons

Opinion

BY JAMES SCONGACK

October 12, 2023

As an essential link of the global supply chain for medical isotopes, Canada has played an important leadership role in the research, development, and production of nuclear medicine technologies for decades.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy